IP Library Granted Patent US 8,216,154
Granted Patent B2
US 8,216,154 · App. 11/317,681 · Granted Jul 10, 2012

Tissue penetration device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,216,154
App. No.
11/317,681
Granted
Jul 10, 2012
Kind
B2
Abstract

A method of lancing the tissue of a patient provides a tissue penetration element with a tip configured to penetrate tissue. The tissue penetration element is disposed in proximity to the tissue of the patient. A lancing cycle is initiated. The lancing cycle advances the tip into the tissue during a penetration stroke and displaces the tissue penetration element proximally over a withdrawal stroke. Tissue data is acquired based on an interaction between the tissue penetration element and the tissue during at least a portion of the lancing cycle.

Claims (12)

1. A method of lancing the tissue of a patient comprising:

(a) providing a tissue penetration element having a tip configured to penetrate tissue;

(b) disposing the tissue penetration element in proximity to the tissue of the patient;

(c) initiating a lancing cycle including advancing a tip of the tissue penetration element into the tissue during a penetration stroke and displacing the tissue penetration element proximally over a withdrawal stroke;

(d) acquiring tissue data based on an interaction between the tissue penetration element and the tissue during at least a portion of the lancing cycle;

(e) using a processor to determine that a skin surface has been contacted by the tissue penetration element when the tip of the tissue penetration element has moved a predetermined distance with respect to an initial position; and position of the tissue penetration element via an electronic drive force generator;

(f) using tissue data for feedback control for the processor and provide for velocity control;

(g) controlling a tissue penetration element velocity into and out of the tissue to allow for compensation for changes in skin thickness and variations in skin hydration; and

(h) achieving spontaneous blood yield.

2. The method of claim 1 , wherein the tissue data obtained during the lancing cycle of (c) to optimize the success of the lancing cycle.

3. The method of claim 1 , wherein the tissue data acquired comprises tissue elasticity data.

4. The method of claim 1 , wherein the tissue data is acquired by measuring resistive forces on the tissue penetration element during the lancing cycle.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2012
From: PELIKAN TECHNOLOGIES, INC.
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 028325/0661 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 024016/0492 →
SECURITY AGREEMENT Recorded Dec 18, 2008
From: PELIKAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021998/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2006
From: FREEMAN, DOMINIQUE; BOECKER, DIRK; ALDEN, DON; BRIGGS, BARRY DEAN; LEONARD, JON HEWITT; FREEMAN, RAY; GOGUE, GEORGE
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 017615/0028 →